Annexin Pharmaceuticals AB Logo

Annexin Pharmaceuticals AB

ANNX | ST

Overview

Corporate Details

ISIN(s):
SE0009664154
LEI:
5493000JP703HGPJEX27
Country:
Sweden
Address:
KAMMAKARGATAN 48, 111 60 Stockholm
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Annexin Pharmaceuticals AB is a clinical-stage biotechnology company focused on developing therapies centered on the human protein Annexin A5. The company's lead drug candidate, ANXV, is a recombinant form of Annexin A5 designed to target the lipid phosphatidylserine (PS), which is exposed on the surface of stressed and damaged cells. By binding to PS, ANXV aims to create a protective shield that counteracts cellular stress, modulates immune responses, and repairs tissue injury. The company is primarily investigating ANXV's therapeutic potential in ophthalmology, specifically for Retinal Vein Occlusion (RVO), where it is positioned as a potential First-in-Class treatment, and in oncology. The drug's unique mechanism of action offers a novel approach for various diseases where PS exposure is a contributing factor.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Annexin Pharmaceuticals AB. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Annexin Pharmaceuticals AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Annexin Pharmaceuticals AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ARIX BIOSCIENCE PLC Logo United Kingdom ARIX
AroCell AB Logo Sweden AROC
Arterra Bioscience Logo
Develops sustainable active ingredients from plant cell cultures for diverse industries.
Italy ABS
Asarina Pharma AB Logo
Developed Sepranolone for neurological disorders like Tourette's, OCD, and menstrual migraine.
Sweden ASAP
Ascelia Pharma Logo
Developing novel drugs for rare cancer conditions, including an oral MRI contrast agent.
Sweden ACE
AVACTA GROUP PLC Logo
Developing targeted cancer therapies with a platform that delivers drugs directly to tumors.
United Kingdom AVCT
BenevolentAI Logo
AI-powered platform that analyzes biomedical data to accelerate drug discovery.
United Kingdom BAI
BerGenBio Logo
Develops first-in-class AXL inhibitors for cancer and severe respiratory infections.
Norway BGBIO
BioArctic Logo
Biopharma developing treatments & diagnostics for neurodegenerative diseases like Alzheimer's.
Sweden BIOA
Biophytis S.A. Logo
Develops oral drugs for age-related neuromuscular, retinal, and metabolic diseases.
France ALBPS